Literature DB >> 6049735

Increase of cerebral catecholamines caused by 3,4-dihydroxyphenylalanine after inhibition of peripheral decarboxylase.

G Bartholini, W P Burkard, A Pletscher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6049735     DOI： 10.1038/215852b0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  53 in total

1.  The contribution of tryptamine to the behavioural effects of l-Tryptophan in tranylcypromine-treated rats.

Authors:  C A Marsden; G Curzon
Journal:  Psychopharmacology (Berl)       Date:  1978-04-14       Impact factor: 4.530

2.  Are high doses of carbidopa a concern? A randomized, clinical trial in Parkinson's disease.

Authors:  Lissa S Brod; Jason L Aldred; John G Nutt
Journal:  Mov Disord       Date:  2012-04-16       Impact factor: 10.338

3.  Parkinsonism-physiology and pharmacology.

Authors:  D B Calne
Journal:  Br Med J       Date:  1971-09-18

4.  The protein Ocular albinism 1 is the orphan GPCR GPR143 and mediates depressor and bradycardic responses to DOPA in the nucleus tractus solitarii.

Authors:  Y Hiroshima; H Miyamoto; F Nakamura; D Masukawa; T Yamamoto; H Muraoka; M Kamiya; N Yamashita; T Suzuki; S Matsuzaki; I Endo; Y Goshima
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

5.  Effect of administration of 5-hydroxytryptophan and an inhibitor of L-aromatic amino acid decarboxylase on glucose metabolism in rat brain.

Authors:  K L Wong; G M Tyce
Journal:  Neurochem Res       Date:  1979-04       Impact factor: 3.996

6.  Elevating serotonin levels in brain with 5-hydroxytryptophan produces hypothermia in rats.

Authors:  M T Lin; C F Chow; Y F Chern; K M Wu
Journal:  Pflugers Arch       Date:  1978-11-30       Impact factor: 3.657

7.  Passage into the rat brain of dopa and dopamine injected into the lateral ventricle.

Authors:  J Constantinidis; J M Gaillard; F Geissbuhler; R Tissot
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

Review 8.  The pharmacology of Parkinson's disease: basic aspects and recent advances.

Authors:  M Da Prada; H H Keller; L Pieri; R Kettler; W E Haefely
Journal:  Experientia       Date:  1984-11-15

Review 9.  Anti-parkinsonian drugs today.

Authors:  N P Quinn
Journal:  Drugs       Date:  1984-09       Impact factor: 9.546

10.  Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial.

Authors:  U K Rinne; E Birket-Smith; E Dupont; E Hansen; M Hyyppä; R Marttila; B Mikkelsen; H Pakkenberg; J Presthus
Journal:  J Neurol       Date:  1975-12-02       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.